Delivery Order SPE2DB20D9214-SPE2DB25FD4VR
Award Date
6/12/25
Potential Completion Date
7/7/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is for the supply of STELARA 90 MG/ML SYRINGE/ML, a pharmaceutical product, with a ceiling value of $146,249.55 and a period of performance through June 11, 2025. DMS Pharmaceutical Group Inc. is a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $16,249.95 and a completion date of June 9, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a prescription medication. The award has a ceiling value of $48,749.85 and a completion date of June 6, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a $162,499.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to support the medical supply needs of military health facilities. The contract has an ultimate completion date of June 25, 2025. DMS Pharmaceutical Group is an established federal contractor, holding...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $32,499.90 order is for 4568462384 ! STELARA 90 MG/ML SYRINGEML and has a completion date of June 20, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a prescription medication, with a ceiling value of $16,441.36 and a performance period through June 3, 2025. DMS Pharmaceutical Group Inc. has also been awarded a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $16,441.36 contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a completion date of April 25, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $24,662.04, is for the delivery of STELARA 90 MG/ML SYRINGEML, a prescription medication. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of pharmaceutical products to federal agencies, including the Department of Defense. The contract has a completion date of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, with a ceiling value of $16,249.95 and a completion date of June 18, 2025. The contract is not set aside for any specific business category. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of pharmaceutical products. The award, valued at $16,441.36, covers the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a period of performance through June 5, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...